AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26761023 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk‐Seeking priming condition
Number of subjects: 0
Study 26761023 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk‐Aversive priming condition
Number of subjects: 0
Study 26761023 — intervention group
Group type: COMPARATOR
Intervention: Control priming condition
Number of subjects: 0
Study 26761023 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory assessment
Number of subjects: 0
Study 26761023 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 0
Study 26761023 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 0
Study 25085517 — intervention group
Group type: EXPERIMENTAL
Intervention: CMT Neuropathy Score (CMTNS) components including Ulnar compound motor action potential (CMAP), leg motor symptoms, arm motor symptoms, leg strength, and sensory symptoms
Number of subjects: 479
Study 25085517 — intervention group
Group type: EXPERIMENTAL
Intervention: 10m-timed walking test (T10MW)
Number of subjects: 479
Study 25085517 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 hole-peg test (9HPT)
Number of subjects: 479
Study 25085517 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot dorsal flexion dynamometry
Number of subjects: 479
Study 25085517 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite of eight components (CMAP, Motor symptoms legs, Motor symptoms arms, Strength of Legs, Sensory symptoms)
Number of subjects: 479
Study 22298375 — intervention group
Group type: EXPERIMENTAL
Intervention: PAE + resin-modified glass ionomer cement (RMGIC)
Number of subjects: 30
Study 22298375 — intervention group
Group type: EXPERIMENTAL
Intervention: PAE + composite resin
Number of subjects: 30
Study 22298375 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated toothpaste
Number of subjects: 30
Study 22298375 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fluoridated toothpaste
Number of subjects: 30
Study 22298375 — intervention group
Group type: COMPARATOR
Intervention: 37% phosphoric acid-etching (PAE)
Number of subjects: 30
Study 22298375 — intervention group
Group type: COMPARATOR
Intervention: No treatment (negative control)
Number of subjects: 30
Study 19653747 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivationally significant stimuli (faces and facial threat)
Number of subjects: 0
Study 19653747 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel temporal order judgment (TOJ) paradigm without cues
Number of subjects: 0
Study 16339292 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 120
Study 16339292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 12789177 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B further diluted with preservative-containing saline
Number of subjects: 15
Study 12789177 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin type B further diluted with preservative-free saline
Number of subjects: 15
Study 10957865 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy plus irradiation
Number of subjects: 0
Study 10957865 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative surgery plus radiation
Number of subjects: 0
Study 10957865 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Gy boost to the tumor bed after 50 Gy to the whole breast
Number of subjects: 0
Study 10957865 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole breast irradiation
Number of subjects: 0
Study 10957865 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiotherapy
Number of subjects: 0
Study 10957865 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation of supraclavicular lymph nodes
Number of subjects: 0
Study 10957865 — intervention group
Group type: COMPARATOR
Intervention: Irradiation of parasternal lymph nodes
Number of subjects: 0
Study 8653163 — intervention group
Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 120
Study 8653163 — intervention group
Group type: COMPARATOR
Intervention: Right lateral position
Number of subjects: 120
Study 8653163 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 120
Study 8653163 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous pH in left lateral position
Number of subjects: 120
Study 8653163 — intervention group
Group type: COMPARATOR
Intervention: Venous pH in right lateral position
Number of subjects: 120
Study 8653163 — intervention group
Group type: COMPARATOR
Intervention: Venous pH in supine position
Number of subjects: 120
Study 8653163 — intervention group
Group type: EXPERIMENTAL
Intervention: Position effects on pH, PaCO2, bicarbonate
Number of subjects: 120
Study 8653163 — intervention group
Group type: EXPERIMENTAL
Intervention: Position effects on PvO2, PvCO2, bicarbonate, venous saturation
Number of subjects: 120
Study 8653163 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated arterial-venous oxygen difference
Number of subjects: 120
Study 1615101 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 55
Study 1615101 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 55
Study 1615101 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine and Haloperidol
Number of subjects: 55
Study 6742743 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam alone or in combination with pentazocine
Number of subjects: 400
Study 6742743 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 400
Study 6742743 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (Valium)
Number of subjects: 400
Study 31204771 — intervention group
Group type: EXPERIMENTAL
Intervention: ∼3 g/d DHA
Number of subjects: 3
Study 31204771 — intervention group
Group type: EXPERIMENTAL
Intervention: ∼3 g/d EPA
Number of subjects: 3
Study 31204771 — intervention group
Group type: COMPARATOR
Intervention: Olive oil control
Number of subjects: 3
Study 25226325 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (8 weeks of bicycle training)
Number of subjects: 20
Study 25226325 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 20
Study 27055965 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame oil blend (20% sesame oil, 80% rice bran oil)
Number of subjects: 300
Study 27055965 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg/d)
Number of subjects: 300
Study 27055965 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sesame oil blend and nifedipine (20 mg/d)
Number of subjects: 300
Study 27055965 — intervention group
Group type: COMPARATOR
Intervention: Control group (normotensives treated with sesame oil blend)
Number of subjects: 300
Study 25194085 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for 15 days
Number of subjects: 144
Study 25194085 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytotherapeutic agents for 30 days plus 15 days antibiotic treatment
Number of subjects: 144
Study 25194085 — intervention group
Group type: COMPARATOR
Intervention: Control group (Antibiotic treatment only for 15 days)
Number of subjects: 144
Study 21680139 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flex posterior cruciate-substituting (PS) design
Number of subjects: 29
Study 21680139 — intervention group
Group type: COMPARATOR
Intervention: High-flex posterior cruciate-retaining (CR) design
Number of subjects: 29
Study 20954287 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA mRNA in lymph node metastasis
Number of subjects: 53
Study 20954287 — intervention group
Group type: EXPERIMENTAL
Intervention: PIK3CA protein expression
Number of subjects: 53
Study 20954287 — intervention group
Group type: EXPERIMENTAL
Intervention: p-Akt protein
Number of subjects: 53
Study 18043478 — intervention group
Group type: EXPERIMENTAL
Intervention: darunavir/ritonavir (400/100 mg) twice a day
Number of subjects: 32
Study 18043478 — intervention group
Group type: COMPARATOR
Intervention: saquinavir/ritonavir (1000/100 mg) twice a day
Number of subjects: 32
Study 18043478 — intervention group
Group type: EXPERIMENTAL
Intervention: darunavir/saquinavir/ritonavir (400/1000/100 mg) twice a day
Number of subjects: 32
Study 16107961 — intervention group
Group type: EXPERIMENTAL
Intervention: Undiluted Lancy-Vaxina vaccine (n=56)
Number of subjects: 112
Study 16107961 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted Lancy-Vaxina vaccine (n=56)
Number of subjects: 112
Study 16107961 — intervention group
Group type: COMPARATOR
Intervention: Previously vaccinated persons
Number of subjects: 112
Study 12391348 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS+PT
Number of subjects: 54
Study 12391348 — intervention group
Group type: COMPARATOR
Intervention: SCS
Number of subjects: 54
Study 9987155 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-vaccination with vaccinia virus
Number of subjects: 99
Study 9987155 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-vaccination at birth and again at 8 years old
Number of subjects: 99
Study 7539852 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide (luteinizing hormone-releasing hormone agonist)
Number of subjects: 50
Study 2305610 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-free 2% lidocaine (80 mg)
Number of subjects: 50
Study 2305610 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric 5% lidocaine (80 mg)
Number of subjects: 50
Study 2305610 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 7386343 — intervention group
Group type: EXPERIMENTAL
Intervention: 167 mg of citrated caffeine
Number of subjects: 25
Study 7386343 — intervention group
Group type: EXPERIMENTAL
Intervention: 324 mg of citrated caffeine
Number of subjects: 25
Study 7386343 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of citrated caffeine
Number of subjects: 25
Study 7386343 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg of caffeine)
Number of subjects: 25
Study 31551249 — intervention group
Group type: EXPERIMENTAL
Intervention: HDV-insulin lispro (HDV-L)
Number of subjects: 176
Study 31551249 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro (LIS)
Number of subjects: 176
Study 27797928 — intervention group
Group type: COMPARATOR
Intervention: High-Carbohydrate Diet (HCD)
Number of subjects: 10
Study 27797928 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 10
Study 25494832 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-frame message
Number of subjects: 0
Study 25494832 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-frame message
Number of subjects: 0
Study 25494832 — intervention group
Group type: COMPARATOR
Intervention: Control message
Number of subjects: 0
Study 22796543 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airways (LMA) and EZ-IO drill kit
Number of subjects: 44
Study 22796543 — intervention group
Group type: COMPARATOR
Intervention: Standard methods of endotracheal intubation (ETI) and central line placement
Number of subjects: 44
Study 21295901 — intervention group
Group type: EXPERIMENTAL
Intervention: Color singleton distractors in the left visual hemifield
Number of subjects: 0
Study 21295901 — intervention group
Group type: EXPERIMENTAL
Intervention: Color singleton distractors
Number of subjects: 0
Study 21295901 — intervention group
Group type: EXPERIMENTAL
Intervention: Easier to detect target
Number of subjects: 0
Study 21295901 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-salient distractor
Number of subjects: 0
Study 19393928 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of the shoulder under anaesthetic
Number of subjects: 53
Study 19393928 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular shoulder injections using steroid with distension
Number of subjects: 53
Study 16675705 — intervention group
Group type: EXPERIMENTAL
Intervention: Serogroup C glycoconjugate vaccine
Number of subjects: 0
Study 16675705 — intervention group
Group type: COMPARATOR
Intervention: Plain polysaccharide vaccine
Number of subjects: 0
Study 12934956 — intervention group
Group type: EXPERIMENTAL
Intervention: Real millimeter wave therapy (MWT) sessions, n=4
Number of subjects: 12
Study 12934956 — intervention group
Group type: COMPARATOR
Intervention: Sham sessions, n=4
Number of subjects: 12
Study 12934956 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic millimeter waves in a random cross-over manner, n=4
Number of subjects: 12
Study 10928302 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting calcium channel blockers
Number of subjects: 0
Study 10928302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8623869 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy colonization with group B streptococci
Number of subjects: 13646
Study 8623869 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics effective against group B streptococci
Number of subjects: 13646
Study 8623869 — intervention group
Group type: EXPERIMENTAL
Intervention: Light colonization with group B streptococci
Number of subjects: 13646
Study 8623869 — intervention group
Group type: COMPARATOR
Intervention: Group B streptococci colonization at 23 to 26 weeks' gestation
Number of subjects: 13646
Study 8623869 — intervention group
Group type: COMPARATOR
Intervention: Group B streptococci colonization at delivery
Number of subjects: 13646
Study 1549403 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemophilus influenzae type b Neisseria meningitidis outer membrane protein conjugate vaccine (PedvaxHIB)
Number of subjects: 40
Study 1549403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 4001836 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of porcine GIP at a dose of 1.0 microgram . kg‐1 . h‐1
Number of subjects: 6
Study 4001836 — intervention group
Group type: COMPARATOR
Intervention: Standard breakfast
Number of subjects: 6
Study 31707844 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated family case conferencing
Number of subjects: 290
Study 31707844 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility policy not to rotate personnel through dementia units
Number of subjects: 290
Study 31707844 — intervention group
Group type: EXPERIMENTAL
Intervention: Designation of nursing manager or registered/enrolled nurse
Number of subjects: 290
Study 31707844 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiary level of education
Number of subjects: 290
Study 31707844 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater experience in dementia care
Number of subjects: 290
Study 31895319 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative study with victim families
Number of subjects: 145
Study 29979421 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative injection of carbon nanoparticles (CNs)
Number of subjects: 102
Study 29979421 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative injection of carbon nanoparticles (CNs)
Number of subjects: 102
Study 26890267 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous preemptive analgesia (IV-PCA) with fentanyl started before skin incision
Number of subjects: 51
Study 26890267 — intervention group
Group type: COMPARATOR
Intervention: Control group (IV-PCA with fentanyl started 5 min after skin incision)
Number of subjects: 51
Study 24528331 — intervention group
Group type: EXPERIMENTAL
Intervention: warfarin transitioned to rivaroxaban 20 mg once daily (group A)
Number of subjects: 96
Study 24528331 — intervention group
Group type: COMPARATOR
Intervention: warfarin followed by placebo once daily (group B)
Number of subjects: 96
Study 24528331 — intervention group
Group type: COMPARATOR
Intervention: rivaroxaban alone 20 mg once daily (group C)
Number of subjects: 96
Study 22222996 — intervention group
Group type: EXPERIMENTAL
Intervention: LipiFlow treatment (12 minutes)
Number of subjects: 139
Study 22222996 — intervention group
Group type: COMPARATOR
Intervention: iHeat Warm Compress (5 minutes daily for 2 weeks)
Number of subjects: 139
Study 22222996 — intervention group
Group type: EXPERIMENTAL
Intervention: LipiFlow treatment (12 minutes) in crossover group
Number of subjects: 139
Study 22222996 — intervention group
Group type: COMPARATOR
Intervention: LipiFlow and iHeat WC
Number of subjects: 139
Study 21144938 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamer Irrigator Aspirator (RIA)
Number of subjects: 19
Study 21144938 — intervention group
Group type: COMPARATOR
Intervention: Standard Reaming (SR)
Number of subjects: 19
Study 17662577 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 51
Study 17662577 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 51
Study 17662577 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 51
Study 15630071 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 59
Study 15630071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 12198044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil target concentration (STC) 0.1 ng/mL
Number of subjects: 45
Study 12198044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil target concentration (STC) 0.2 ng/mL
Number of subjects: 45
Study 12198044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil target concentration (STC) 0.3 ng/mL
Number of subjects: 45
Study 12198044 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol target concentration 5.0 microg/mL
Number of subjects: 45
Study 12198044 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol target concentration 4.0 microg/mL
Number of subjects: 45
Study 12198044 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol target concentration 2.5 microg/mL
Number of subjects: 45
Study 11575576 — intervention group
Group type: COMPARATOR
Intervention: Low group (160 g of tomato juice plus 320 g of control drink)
Number of subjects: 31
Study 11575576 — intervention group
Group type: COMPARATOR
Intervention: High group (480 g of tomato juice)
Number of subjects: 31
Study 11575576 — intervention group
Group type: COMPARATOR
Intervention: Control group (480 g of control drink)
Number of subjects: 31
Study 9551876 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 228
Study 9551876 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 228
Study 8141442 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl/midazolam (1 mg/25 mg; dosage 0.1 ml/kg/h)
Number of subjects: 45
Study 8141442 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine/midazolam (250 mg/25 mg; dosage 0.1 ml/kg/h)
Number of subjects: 45
Study 8141442 — intervention group
Group type: COMPARATOR
Intervention: Enflurane (mean concentration 1.5 vol%)
Number of subjects: 45
Study 2900980 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (n = 53) - second-look laparotomy followed by cyclical oral chlorambucil
Number of subjects: 166
Study 2900980 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (n = 56) - second-look laparotomy followed by total abdominal and pelvic irradiation
Number of subjects: 166
Study 2900980 — intervention group
Group type: COMPARATOR
Intervention: Group C (n = 57) - oral chlorambucil without second-look operation
Number of subjects: 166
Study 29095478 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory physical and psychosocial workplace intervention (PIPPI)
Number of subjects: 415
Study 29095478 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 415
Study 28807139 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health (MH) recognition in EMR
Number of subjects: 180
Study 28807139 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health (MH) service use
Number of subjects: 180
Study 28807139 — intervention group
Group type: EXPERIMENTAL
Intervention: EMR documentation of MH diagnoses
Number of subjects: 180
Study 28807139 — intervention group
Group type: EXPERIMENTAL
Intervention: EMR MH diagnosis
Number of subjects: 180
Study 28807139 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher internal locus of control
Number of subjects: 180
Study 28807139 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor physical health-related QOL
Number of subjects: 180
Study 26565927 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreous ranibizumab (0.5 mg)
Number of subjects: 305
Study 26565927 — intervention group
Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP)
Number of subjects: 305
Study 23095128 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrapro® mesh (Ethicon)
Number of subjects: 144
Study 23095128 — intervention group
Group type: EXPERIMENTAL
Intervention: Vypro® mesh (Ethicon)
Number of subjects: 144
Study 23095128 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene® light mesh (Ethicon)
Number of subjects: 144
Study 21248668 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2-enriched water immersion
Number of subjects: 25
Study 21248668 — intervention group
Group type: COMPARATOR
Intervention: Normal spa water immersion
Number of subjects: 25
Study 18465343 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pamidronate (150 mg twice daily for 4 years)
Number of subjects: 953
Study 18465343 — intervention group
Group type: COMPARATOR
Intervention: No pamidronate (control group)
Number of subjects: 953
Study 16540947 — intervention group
Group type: EXPERIMENTAL
Intervention: 4INJ group (n = 42) receiving four injections of methylprednisolone sodium succinate
Number of subjects: 128
Study 16540947 — intervention group
Group type: EXPERIMENTAL
Intervention: 1INJ group (n = 42) receiving one injection of methylprednisolone followed by three injections of normal saline
Number of subjects: 128
Study 16540947 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 43) receiving four injections of normal saline
Number of subjects: 128
Study 12669747 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial cuing effects with distractor interference
Number of subjects: 0
Study 12669747 — intervention group
Group type: COMPARATOR
Intervention: Spatial cuing effects without distractors
Number of subjects: 0
Study 10630947 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous injection of 1.8 mL of 3% mepivacaine
Number of subjects: 48
Study 10630947 — intervention group
Group type: COMPARATOR
Intervention: Mock intraosseous injection
Number of subjects: 48
Study 8922326 — intervention group
Group type: EXPERIMENTAL
Intervention: Study catheter (Berman catheter)
Number of subjects: 36
Study 8922326 — intervention group
Group type: COMPARATOR
Intervention: Standard selective catheter technique
Number of subjects: 36
Study 8922326 — intervention group
Group type: EXPERIMENTAL
Intervention: Study catheter
Number of subjects: 36